Targeting the homologous recombination pathway by small molecule modulators
Fei Huang1, Alexander V Mazin1
1Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, PA 19102-1192, United States.
Bioorganic & Medicinal Chemistry Letters
|May 27, 2014
Summary
Small molecule compounds targeting the homologous recombination (HR) pathway are increasingly used as research tools and potential therapeutics. This review covers recent advancements in developing these modulators for biological pathway studies and disease treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Small molecule compounds (MW <500 Da) are widely used to modulate protein functions in biological pathways.
- The homologous recombination (HR) pathway has recently gained attention as a target for small molecule modulators.
- These modulators serve dual purposes: as research tools and as potential therapeutic agents.
Purpose of the Study:
- To review the progress in the development of small molecule modulators targeting the homologous recombination (HR) pathway.
- To highlight the applications of these modulators in biological research and drug discovery.
Main Methods:
- Literature review of recent studies on small molecule modulators of HR.
- Analysis of the development strategies and applications of these compounds.
Main Results:
- Significant progress has been made in identifying and developing small molecule modulators for the HR pathway.
- These compounds show promise as research tools for dissecting HR functions and as potential drug candidates for various pathologies.
Conclusions:
- Small molecule modulators of HR represent a rapidly advancing field with substantial potential.
- Continued research in this area is expected to yield novel tools and therapeutics.
Related Concept Videos
Homologous Recombination
58.8K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
58.8K
Homologous Recombination
6.2K
6.2K
Conservative Site-specific Recombination and Phase Variation
5.7K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
5.7K
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Crossing Over
6.3K
Crossing over is the exchange of genetic information between homologous chromosomes during prophase I of meiosis I. Genetic recombination gives rise to allelic diversity in the newly formed daughter cells. In humans, crossing over produces genetically distinct haploid egg and sperm cells that undergo fertilization to produce unique offspring. Before cell division starts, the germ cell’s chromosome(s) undergo duplication in the S phase of the cell cycle. As the cells enter prophase I,...
6.3K
In-vitro Mutagenesis
14.8K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.8K


